The Pharmaceutical Powerhouses of Latin America: Mexico, Brazil, Argentina, and Colombia

The regional market is estimated at $136.5 billion in 2024 and is projected to grow at a 9.7% CAGR through 2026, making it one of the fastest-growing pharmaceutical regions globally.

At the center of this expansion are four key markets: Mexico, Brazil, Argentina, and Colombia. Together, these countries represent the largest pharmaceutical ecosystems in Latin America, combining strong domestic demand, evolving regulatory frameworks, and growing pharmaceutical logistics infrastructure. Pharmaceutical sales in these four markets alone are expected to reach roughly $90 billion in 2024 and expand to nearly $100 billion by 2027.

The chart highlights the steady expansion of pharmaceutical sales across these markets, rising from $67.4 billion in 2019 to a projected $99.8 billion by 2027, reflecting a 5% CAGR. While the pandemic created a temporary contraction in 2020 ($58.2 billion), demand quickly rebounded as healthcare utilization normalized and governments reinforced pharmaceutical supply chains.

Several structural factors are driving this growth. The prevalence of chronic diseases such as diabetes, cardiovascular conditions, and obesity is increasing across Latin America due to urbanization, dietary changes, and aging populations. These trends are raising long-term demand for prescription drugs, specialty pharmaceuticals, and biologics. At the same time, rising middle-class incomes are expanding access to healthcare services and medications.

However, growth also introduces complexity. Pharmaceutical supply chains must manage strict regulatory compliance, temperature-controlled distribution, and cross-border trade logistics. Cold-chain capacity, traceability technologies, and compliance with Good Distribution Practices (GDP) are becoming essential capabilities for logistics operators across the region.

Mexico: A Strategic Gateway for Pharmaceutical Trade

Mexico stands as one of the most important pharmaceutical markets in Latin America, accounting for a significant share of regional demand and production. The pharmaceutical industry represents roughly 5% of the country’s GDP, supported by more than 900 pharmaceutical companies operating across the sector.

The country’s proximity to the United States gives it a strategic advantage. Mexico is the region’s largest pharmaceutical exporter and serves as an important manufacturing and distribution hub linking North America and Latin America.

Pharmaceutical logistics plays a crucial role in sustaining this ecosystem. The industry spends roughly 4% of input costs on transportation, with logistics expenditures estimated at $2.65 billion in 2023 and growing steadily through 2027. Major logistics operators such as DHL Supply Chain, Grupo Traxion, and specialized providers like Medistik support cold-chain storage, controlled transport, and regulatory compliance across the supply chain.

Mexico’s pharmaceutical market also tends to favor branded drugs over generics, making it an attractive destination for multinational pharmaceutical companies launching innovative therapies.

Brazil: Scale and Domestic Manufacturing Strength

Brazil is the largest pharmaceutical market in Latin America and a major driver of regional production capacity. The country combines strong domestic manufacturing with a vast public healthcare system, the Sistema Único de Saúde (SUS), which is the world’s largest government-run healthcare system by number of beneficiaries.

Brazil’s pharmaceutical industry has expanded rapidly over the past decade, supported by government incentives and policies that encourage domestic production. Local manufacturers play a major role in supplying generic medicines and “copies” for the domestic market.

The logistics infrastructure supporting the industry is also significant. Transportation spending reached $3.21 billion in 2023 and is expected to grow at a 6% annual rate through 2027. Regulatory oversight from ANVISA, Brazil’s health surveillance agency, imposes strict requirements for pharmaceutical storage, transport monitoring, reverse logistics, and hygiene standards.

Major logistics providers in the sector include Brasspress Farma, DHL Supply Chain, and DRS Group, which specialize in pharmaceutical transport, cold-chain logistics, and import-export services.

Argentina: A Rare Case of Strong Domestic Pharma Champions

Argentina’s pharmaceutical industry stands out within Latin America because of the strength of its domestic pharmaceutical companies. Unlike many emerging markets where multinational firms dominate, Argentina has a long-established network of locally owned laboratories that command a significant share of the market.

The chart illustrates this contrast clearly. In Argentina, the top pharmaceutical companies include several domestic laboratories such as Roemmers, Elea Phoenix, Gador, Casasco, Montpellier, and Bagó. These Argentine-owned companies compete directly with global pharmaceutical firms and have built strong regional export capabilities.

This domestic strength differentiates Argentina from the other three markets, where multinational pharmaceutical companies typically dominate the top revenue rankings.

Despite economic challenges including inflation, currency volatility, and limited R&D investment, Argentina remains a major pharmaceutical manufacturing hub. The industry employs over 43,000 people directly and roughly 120,000 indirectly.

Logistics demand is significant because the country imports active pharmaceutical ingredients while exporting finished pharmaceutical products across Latin America. Transportation spending in the sector reached approximately $390 million in 2023, with moderate growth expected through 2027.

Key logistics providers include Andreani, Scienza, and Log-In, which support nationwide distribution and specialized pharmaceutical transport services.

Colombia: A Rapidly Growing Pharmaceutical Market

Colombia represents the fastest-growing pharmaceutical logistics market among the four countries. The industry accounts for approximately 1.5% of national GDP and employs more than 47,000 people.

Although local pharmaceutical production exists, the country still relies heavily on imports. Domestic drugs represent roughly 80% of units sold, but only 33% of total revenue, indicating that higher-value therapies are still largely imported.

Recent investments aim to strengthen domestic manufacturing capacity. Several new production facilities are under development, including a major vaccine plant in Bogotá operated by Sinovac.

Logistics demand is expanding quickly as well. Transportation spending reached roughly $240 million in 2023 and is projected to grow at an 8% annual rate through 2027, the fastest pace among the four markets.

Cold-chain infrastructure is becoming increasingly important, particularly as Colombia expands its capabilities in biologics and vaccine production.

A Growing Opportunity for Pharmaceutical Logistics

Across Mexico, Brazil, Argentina, and Colombia, the pharmaceutical industry is entering a phase of steady expansion supported by demographic shifts and healthcare investment. At the same time, the sector’s operational complexity is increasing.

Temperature-controlled distribution, regulatory compliance, cross-border trade management, and security requirements make pharmaceutical logistics one of the most specialized segments of the supply chain.

For logistics operators, the four largest pharmaceutical markets in Latin America represent a growing opportunity. As pharmaceutical sales approach $100 billion by 2027, the companies capable of delivering reliable cold-chain infrastructure, regulatory expertise, and scalable distribution networks will become essential partners in the region’s healthcare ecosystem.

Sources & References:

Americas Market Intelligence. (2023). Latam`s Pharma Logistics Market: A Lucrative Opportunity for Operators. https://americasmi.com/insights/latams-pharma-logistics-market/ 

Americas Market Intelligence. (2025). The 2025 Logistics Ecosystem in Latin America. https://americasmi.com/ami-infographics/2025_AMI_Logistics-Ecosystem-Latin-America-2025_opt.pdf 

World Bank. (2022). Pharmaceuticals in Latin America and the Caribbean. https://openknowledge.worldbank.org/server/api/core/bitstreams/353c099b-8aae-58f5-8a6d-c07eef593556/content